Ceribell is a groundbreaking medical technology company that has revolutionized neurological care through its Rapid EEG system, a portable, AI-enabled device that delivers real-time brain monitoring at the point of care. Unlike traditional EEG systems, which require specialized staff and can take hours or even days to implement, Ceribell’s Rapid EEG provides immediate, bedside access to seizure diagnostics within minutes. This allows frontline providers, regardless of their neurology training, to detect non-convulsive seizures and status epilepticus swiftly, especially in critically ill patients. For rural hospitals, where neurologists and EEG techs are rarely on-site, Ceribell bridges a critical gap, enabling timely interventions that improve outcomes and reduce dependence on transfers to tertiary centers.

By enabling accurate, on-demand neurological assessment in emergency departments and ICUs, Ceribell helps rural hospitals keep more patients in-house, avoiding unnecessary ICU admissions or costly transfers for EEG monitoring. This not only improves patient outcomes and family satisfaction but also retains revenue within the local health system, transforming what would be a financial loss into an opportunity for sustainable care delivery. With Ceribell, rural hospitals gain a scalable solution that enhances diagnostic confidence, reduces length of stay, and positions them as capable centers for advanced acute care, without needing to expand full-time neurology services.

Learn more at ceribell.com.